
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $143.9M | -- | -- | $0.09 | -- |
08/29/2025 | Q2 | $137.2M | -- | -- | $0.03 | -- |
05/08/2025 | Q1 | $134.1M | $136M | -$0.18 | $0.02 | -$0.20 |
03/05/2025 | Q4 | $150.3M | $150.4M | -$0.59 | $0.11 | -$0.70 |
11/13/2024 | Q3 | $139.5M | $140M | -$0.37 | -$0.04 | -$0.34 |
08/29/2024 | Q2 | $146.3M | $138M | -$0.36 | -$0.05 | -$0.31 |
05/29/2024 | Q1 | $143.8M | $144.1M | -$0.37 | -$0.07 | -$0.31 |
03/07/2024 | Q4 | $154.2M | $156.3M | -$0.22 | $0.02 | -$0.24 |
11/16/2023 | Q3 | -- | -- | -$0.68 | $0.03 | -$0.71 |
08/09/2023 | Q2 | -- | -- | -$0.56 | $0.01 | -$0.57 |
05/16/2023 | Q1 | -- | -- | -$0.33 | -$0.06 | -$0.27 |
03/02/2023 | Q4 | -- | -- | -$0.04 | $0.03 | -$0.07 |
11/10/2022 | Q3 | -- | -- | $0.28 | $0.02 | $0.26 |
08/03/2022 | Q2 | -- | -- | -$0.37 | -$0.01 | -$0.36 |
05/16/2022 | Q1 | -- | -- | -$0.32 | -$0.04 | -$0.28 |
02/23/2022 | Q4 | -- | -- | -$0.07 | -$0.01 | -$0.06 |
11/04/2021 | Q3 | -- | -- | -$0.28 | -$0.06 | -$0.22 |
08/05/2021 | Q2 | -- | -- | -$0.31 | -$0.07 | -$0.24 |
05/05/2021 | Q1 | -- | -- | -$0.32 | -$0.07 | -$0.25 |
03/01/2021 | Q4 | -- | -- | $0.20 | -$0.00 | $0.20 |
11/12/2020 | Q3 | -- | -- | -$7.35 | -$0.07 | -$7.28 |
08/05/2020 | Q2 | -- | -- | -$0.51 | -$0.20 | -$0.31 |
05/14/2020 | Q1 | -- | -- | -$0.40 | -$0.05 | -$0.35 |
02/26/2020 | Q4 | -- | -- | -$0.05 | $0.20 | -$0.25 |
11/13/2019 | Q3 | -- | -- | -$0.13 | $0.12 | -$0.25 |
07/31/2019 | Q2 | -- | -- | $0.02 | $0.15 | -$0.13 |
05/02/2019 | Q1 | -- | -- | -$0.04 | $0.06 | -$0.10 |
03/07/2019 | Q4 | -- | -- | $0.12 | $0.19 | -$0.07 |
11/01/2018 | Q3 | -- | -- | -$0.01 | $0.05 | -$0.06 |
08/01/2018 | Q2 | -- | -- | -$0.08 | -- | -- |
05/02/2018 | Q1 | -- | -- | -$0.24 | -- | -- |
02/28/2018 | Q4 | -- | -- | -$0.19 | -- | -- |
11/14/2017 | Q3 | -- | -- | -$0.19 | -- | -- |
08/09/2017 | Q2 | -- | -- | -$0.11 | -- | -- |
05/16/2017 | Q1 | -- | -- | -$0.26 | -- | -- |
03/09/2017 | Q4 | -- | -- | -$0.30 | -- | -- |
11/15/2016 | Q3 | -- | -- | -$0.40 | -- | -- |
08/04/2016 | Q2 | -- | -- | -$0.36 | -- | -- |
05/09/2016 | Q1 | -- | -- | -$0.44 | -- | -- |
03/03/2016 | Q4 | -- | -- | -$4.43 | -- | -- |
11/04/2015 | Q3 | -- | -- | -$17.35 | -- | -- |
Stratasys reported $136M worth of top line sales in its most recent quarter.
Stratasys announced earnings per share of -$0.18 which represents a miss of analyst forecast a $0.02 per share.
Stratasys reported $60.2M that represents $0.84 per share over the last quarter.
Stratasys's earnings are forecast to grow from -$1.70 per share to $0.05 per share next year representing an increase of --.
Stratasys's next earnings date is August 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.